The use of methadone “as needed”, is it justified?

John F. Peppin, DO, FACP

doi:10.5055/jom.2009.0001

Authors

John F. Peppin, DO, FACP

DOI:

https://doi.org/10.5055/jom.2009.0001

Keywords:

-

Author Biography

John F. Peppin, DO, FACP

Director, Clinical Research Division, The Pain Treatment Center of the Bluegrass; Clinical Associate Professor, University of Kentucky, College of Pharmacy; Associate Medical Director, Hospice of the Bluegrass, Lexington, Kentucky.

References

National Drug Intelligence Center: Methadone diversion, abuse and misuse: Deaths increasing at alarming rate. Available at http://www.usdoj.gov/ndic/pubs25/25930/index.htm#legit. Accessed October 21, 2008.

Webster LR, Choi Y, Desai H, et al.: Sleep-disordered breathing and chronic opioid therapy. Pain Med. 2008; 9(4): 425-432.

Caravati EM, Grey T, Nangle B, et al.: Increase in poisoning deaths caused by non-illicit drugs-Utah, 1991-2003. MMWR Morb Mortal Wkly Rep. 2005; 54(2): 33-36.

US WV: Feds act on methadone deaths (Series - Part 11Of 11), Source: Charleston Gazette (WV). Copyright: 2006 Charleston Gazette. Available at http://www.wvgazette.com/(http://www.wvgazette.com/) FEDS ACT ON METHADONE DEATHS. Accessed October 22, 2008.

Lipman AG: Methadone: A double-edged sword. J Pain Palliat Care Pharmacother. 2005; 19(4): 3-4

Methadone Hydrochloride. In DRUGDEX System [Internet Database]. Greenwood Village, Colorado: Thomson Healthcare.

Lugo RA, Satterfield KL, Kern SE: Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother. 2005; 19(4): 13-24.

Eap C, Buclin T, Baumann P: Interindividual variability of the clinical pharmacokinetics of methadone. Clin Pharmacokinet. 2002; 41(14): 1153-1193.

Fishman SM, Wilsey B, Nahajan G, et al.: Methadone reincarnated: Novel clinical applications with related concerns. Pain Med. 2002; 3(4): 339-348.

Nilssen MI, Meresaar U, Anggård E: Clinical phramcokinetics of methadone. Acta Anaesthesiol Scand Suppl. 1982; 74: 66-69.

Paalzow L, Nilsson L, Stenberg P: Pharmacokinetic basis for optimal methadone treatment of pain in cancer patients. Acta Anaesthesiol Scand Suppl. 1982; 74: 55-58.

Garrido MJ, Trocóniz IF: Methadone: A review of its pharmacokinetic/pharmacodynamic properties. J Pharmacol Toxicol Methods. 1999; 42(2): 61-66.

Brown R, Kraus C, Fleming M, et al.: Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgrad Med J. 2004; 80: 654-659.

Lacy CF, Armstrong LL, Goldman MP, et al. (eds.): Methadone. Drug Information Handbook, 9th ed., Cleveland, OH: Lexi-Comp, 2001-2002.

Berkowitz BA: The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone. Clin Pharmacokinet. 1976; 1: 219-230.

Pereira J, Lawlor P, Vigano A, et al.: Equianalgesic dose ratios for opioids. A critical review and proposals for long-term dosing. J Pain Symptom Manage. 2001; 22: 672-687.

Gammaitoni AR, Fine P, Alvarez N, McPherson ML & Bergmark S. Clinical application of opioid equianalgesic data. Clin J Pain. 2003; 19: 286-297.

Weschules DJ, Bain KT: A systematic review of opioid conversion ratios used with methadone for the treatment of pain. Pain Med. 2008; 9(5): 595-612.

Ehret GB, Desmeules JA, Broers B: Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology. Expert Opin Drug Saf. 2007; 6: 289-303.

Farney RJ, Walker JM, Boyle KM, et. al.: Adaptive seroventilation (ASV) in patients with sleep disordered breathing associated with chronic opioid medications for non-malignant pain. J Clin Sleep Med. 2008; 4(4): 311-319. Webster 2007.

Walker JM, Farney RJ, Rhondeau SM, et. al.: Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med. 2007; 3(5): 455-461.

Toombs JD, Kral LA: Methadone treatment for pain states. Am Fam Physician. 2005; 71: 1353-1358.